MX9305152A - METHOD FOR THE TREATMENT OF OBSTRUCTIVE AND REVERSIBLE DISEASES OF THE RESPIRATORY TRACT. - Google Patents

METHOD FOR THE TREATMENT OF OBSTRUCTIVE AND REVERSIBLE DISEASES OF THE RESPIRATORY TRACT.

Info

Publication number
MX9305152A
MX9305152A MX9305152A MX9305152A MX9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A
Authority
MX
Mexico
Prior art keywords
obstructive
respiratory tract
treatment
diseases
reversible
Prior art date
Application number
MX9305152A
Other languages
Spanish (es)
Inventor
Catherine Hallam
Stephen Thomas Harper
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of MX9305152A publication Critical patent/MX9305152A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere al tratamiento novedoso de enfermedades obstructivas y revestibles de las vías respiratorias con el uso de compuestos macrocíclicos y a las formulaciones farmacéuticas que incluyen a tales compuestos.The invention relates to the novel treatment of obstructive and lining diseases of the respiratory tract with the use of macrocyclic compounds and to pharmaceutical formulations including such compounds.

MX9305152A 1992-08-25 1993-08-25 METHOD FOR THE TREATMENT OF OBSTRUCTIVE AND REVERSIBLE DISEASES OF THE RESPIRATORY TRACT. MX9305152A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929218027A GB9218027D0 (en) 1992-08-25 1992-08-25 Novel method of treatment

Publications (1)

Publication Number Publication Date
MX9305152A true MX9305152A (en) 1994-05-31

Family

ID=10720906

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305152A MX9305152A (en) 1992-08-25 1993-08-25 METHOD FOR THE TREATMENT OF OBSTRUCTIVE AND REVERSIBLE DISEASES OF THE RESPIRATORY TRACT.

Country Status (6)

Country Link
AU (1) AU4967193A (en)
GB (1) GB9218027D0 (en)
IL (1) IL106751A0 (en)
MX (1) MX9305152A (en)
WO (1) WO1994004148A1 (en)
ZA (1) ZA936137B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
MXPA02004193A (en) 1999-10-29 2002-12-13 Inhale Therapeutic Syst Dry powder compositions having improved dispersivity.
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
AR035411A1 (en) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co USE OF A TACROLIMUS DERIVATIVE TO MANUFACTURE A NEUROTROPHIC AGENT, COMPOSITIONS AND MANUFACTURING ITEMS OR KITS THAT UNDERSTAND IT, METHOD FOR MANUFACTURING AN AGENT THAT UNDERSTANDS AND FABRICS AND GRAINTS WITH A NERVOUS CELL TREATED WITH THIS COMPOSITE
EP1706117A1 (en) * 2004-01-20 2006-10-04 Astellas Pharma Inc. Method for treating erectile dysfunction
TW201821076A (en) 2016-11-10 2018-06-16 瑞士商諾華公司 BMP potentiators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630866B2 (en) * 1987-12-09 1992-11-12 Fisons Plc Macrocyclic compounds
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
GR1001225B (en) * 1989-09-14 1993-06-30 Fisons Plc Novel macrocyclic compositions and new application method thereof
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds

Also Published As

Publication number Publication date
GB9218027D0 (en) 1992-10-14
IL106751A0 (en) 1993-12-08
AU4967193A (en) 1994-03-15
WO1994004148A1 (en) 1994-03-03
ZA936137B (en) 1994-02-21

Similar Documents

Publication Publication Date Title
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
BR0008276A (en) Combinations of formoterol and fluticasone propionate for asthma
NO20022014L (en) A solid oral controlled release dosage form containing hydrocodone
BR9406979A (en) Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound
ES2126766T3 (en) TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT.
BR9808812A (en) Composition comprising crystalline, finely divided budesonide particles
NZ229891A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
DE69429202D1 (en) Therapeutic agent for diseases of the digestive tract
ES2145818T3 (en) USE OF (S) - (-) - ALPHA-ETHYL-2-OXO-1-PIRROLIDIN-ACETAMIDE FOR THE PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF ANXIETY.
ES2147788T3 (en) 3,4-DIARILCROMANOS FOR THE TREATMENT OF DERMATITIS.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
BR9611555A (en) Compounds pharmaceutical formulation use of a compound process to treat a reversible obstructive airway disease and to prepare the compound
AR010984A1 (en) NEW ESTERS OF PLEUROMUTILINE, AND THE ACID 1-AZABICICLO-4- CARBANILCARBANICO; PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9305152A (en) METHOD FOR THE TREATMENT OF OBSTRUCTIVE AND REVERSIBLE DISEASES OF THE RESPIRATORY TRACT.
ES556864A0 (en) PROCEDURE FOR OBTAINING SUBSTITUTED BENZOPYRANS.
ES2079832T3 (en) CHENODEOXICOLICO ACID OR URSODEOXICOLICO ACID FOR THE TREATMENT OF DISEASES OF THE RESPIRATORY ORGANS.
AR018347A1 (en) 1H-INDAZOLES 1,5 AND 3-O-SUBSTITUTES AND ITS PHYSIOLOGICALLY TOLERABLE SALTS, USE OF THE SAME FOR THE PREPARATION OF MEDICINES, PROCEDURES TO PREPARE SUCH COMPOUNDS, THE COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS THAT THE COMPOSITION AND COMPOSITION
ITMI910456A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
IT1151953B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AFFECTIONS OF THE ORAL CAVITY
NO961797D0 (en) Use of benzopyran derivatives for the preparation of pharmaceutical compositions intended for the treatment of pathologies associated with the Na + -independent C1-HCO3 yields
IT1241079B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
BR9407862A (en) Flavin compound flavin derived from flavin or a mixture comprising two or more of these pharmaceutical composition and process for treatment by prophylaxis or therapy of disease caused by viral infection
ID21369A (en) PHARMACEUTICAL COMPOSITION FOR HEALING OF DISEASES CAUSED BY VIRUS
MX9305151A (en) METHOD FOR THE TREATMENT OF SKIN DISEASES.
ES2161809T3 (en) USE OF OSTEOBLASTIC PROLIFERATIVE FACTOR.